Regulated information

Universal registration document 2023 XBRL version

Universal Registration Document including the Annual Financial Report

Universal registration document 2023

Universal Registration Document including the Annual Financial Report

ANNUAL RESULTS 2023 (slideshow)

01.2023 Highlights
02.2023 Consolidated financial statements
03.Strategy and outlook

Universal registration document 2022

Universal Registration Document including the Annual Financial Report

Document d’enregistrement universel (URD) 2022 version XBRL

Document d'enregistrement universel 2022 incluant le rapport financier annuel

[VIDEO] Présentation des résultats annuels 2022 -French

Présentation analystes & investisseurs - 23 Mars 2023

ANNUAL RESULTS 2022 (slideshow)

01.2022 Highlights
02.2022 Consolidated financial statements
03.Strategy and outlook

Vétoquinol : 80 years striving for animal health worldwide

Founded in 1933, Vétoquinol is now a leading global animal health company.
The number 10 global animal health company and the third
largest in France, the Vétoquinol Group combines sustainability,
growth and independence in an increasingly competitive world
market.
Committed to the protection and well-being of both animals
and people, Vétoquinol creates, develops and sells veterinary
drugs and non-medical products all over the world.
The company is widely reputed for its expertise in the fields of infectious diseases, pain and inflammation in livestock (cattle and pigs) and pets (dogs and cats).
For over 80 years, Vétoquinol's pursuit of growth has been underpinned by strong values of team spirit, performance and the sharing of corporate culture and know-how with customers, vets, breeders, partners and employees alike.

Financial statements 2012

1.1CONSOLIDATED FINANCIAL STATEMENTS p.4

Reference Document 2012 (in french)

Reference Document 2012 (in french)